Topiramate in migraine progression
نویسندگان
چکیده
منابع مشابه
Topiramate for migraine prophylaxis.
Topiramate is a neurmodulatory compound with neuron stabilizing properties and is approved for the preventive treatment of migraine in several countries [5]. Several small and large trials have reported good efficacy and safety of topiramate in migraine prophylaxis in adults [6]. The present study was done to study the role of topiramate in migraine prophylaxis in children who either failed to ...
متن کاملProphylaxis of Childhood Migraine: Topiramate Versus Propranolol
OBJECTIVE Headache is a common disabling neurological disorder and migraine comprises more than half the causes of recurrent headaches in children. Despite extended prevalence of this type of headache there is lack of evidence about best drug treatment for migraine. So we aimed to compare the therapeutic effects of these drugs on childhood migraine. MATERIALS & METHODS In the current study, a...
متن کاملTopiramate for migraine prevention: an update.
Although the drug topiramate initially was developed for the treatment of epilepsy and received its first US Food and Drug Administration (FDA) approval for that purpose, it subsequently was shown to be effective for the prevention of migraine headaches and is FDA approved for that indication as well. Migraine and epilepsy share a considerable number of biologic and clinical features, and it fo...
متن کاملEfficacy of Topiramate in Migraine Prophylaxis: a Randomized Controlled Study*
Topiramate has been under investigation for the past several years as a prophylactic agent for migraine and other headache disorders. Studies to date have shown it to be safe and effective. As with other antiepileptic drugs, its exact mechanisms of action are not yet known, or at least, the mechanisms that are important in its efficacy in migraine are not yet defined. Topiramate acts on several...
متن کاملTesting the combination beta-blocker plus topiramate in refractory migraine.
OBJECTIVE To test treatment combining a beta-blocker plus topiramate in migraine patients previously resistant to the two medications in monotherapy. PATIENTS AND METHODS Those patients who had not responded to a beta-blocker and topiramate received combined treatment. RESULTS Fifty-eight patients (47 women, age 25-76 years) received the combined treatment. Thirty-three (57%) met criteria f...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Journal of Headache and Pain
سال: 2009
ISSN: 1129-2369,1129-2377
DOI: 10.1007/s10194-009-0164-9